Citation: M. Kloke et al., Toxicity and/or insufficient analgesia by opioid therapy: risk factors andthe impact of changing the opioid. A retrospective analysis of 273 patients observed at a single center, SUPP CARE C, 8(6), 2000, pp. 479-486
Citation: O. Kloke et al., Interferon alfa as primary treatment of chronic myeloid leukemia: long-term followup of 71 patients observed in a single center, LEUKEMIA, 14(3), 2000, pp. 389-392
Authors:
Adamietz, A
Beck, D
Gralow, I
Grond, S
Hanekop, G
Hankemeier, U
Heidemann, E
Hoffmann, L
Jage, J
Kath, R
Klaschik, E
Kloke, M
Kloke, O
Lempa, M
Lindena-Glaess, G
Nauck, F
Radbruch, L
Sohn, W
Strumpf, M
Tietze-Schillings, G
Tronnier, V
Weber, M
Zeilhofer, HU
Citation: A. Adamietz et al., Guidelines for cancer pain therapy, TUMORDIAGN, 20(4), 1999, pp. 105-129
Authors:
Kloke, O
Klaassen, U
Oberhoff, C
Hartwich, G
Szanto, J
Wolf, E
Heckmann, M
Huhn, R
Stephan, L
Schnepper, U
Donsbach, GM
Bechtel, C
Rudolph, R
Berke, A
Borquez, D
Hawig, I
Hirche, H
Schindler, AE
Seeber, S
Becher, R
Citation: O. Kloke et al., Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial, BREAST CANC, 55(1), 1999, pp. 51-59